Literature DB >> 3595249

Prognostic role of eosinophils in pulmonary fibrosis.

M W Peterson, M Monick, G W Hunninghake.   

Abstract

Idiopathic pulmonary fibrosis (IPF) and pulmonary fibrosis associated with a collagen vascular disorder (PF-CVD) are chronic inflammatory lung disorders which may be characterized in various subgroups of patients by increased numbers of macrophages, neutrophils, lymphocytes, and/or eosinophils. Previous studies have suggested that the cell populations recovered with bronchoalveolar lavage (BAL) may be important in predicting disease progression and response to therapy. We evaluated this hypothesis in 27 patients by determining if the cell populations recovered with BAL differed between patients who improved, remained stable, or worsened in their pulmonary functions (as defined by at least a 15 percent change in forced vital capacity) over a six-month observation period. The findings suggested that BAL eosinophilia may be a marker of progressive lung disease in patients with IPF and PF-CVD.

Entities:  

Mesh:

Year:  1987        PMID: 3595249     DOI: 10.1378/chest.92.1.51

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  36 in total

Review 1.  Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis.

Authors:  A Wells
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

Review 2.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

Review 3.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease.

Authors:  Thomas A Wynn; Thirumalai R Ramalingam
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

4.  Epithelial Expression of an Interstitial Lung Disease-Associated Mutation in Surfactant Protein-C Modulates Recruitment and Activation of Key Myeloid Cell Populations in Mice.

Authors:  Alessandro Venosa; Jeremy Katzen; Yaniv Tomer; Meghan Kopp; Sarita Jamil; Scott J Russo; Surafel Mulugeta; Michael F Beers
Journal:  J Immunol       Date:  2019-03-25       Impact factor: 5.422

Review 5.  Idiopathic pulmonary fibrosis and a role for autoimmunity.

Authors:  Gerard F Hoyne; Hannah Elliott; Steven E Mutsaers; Cecilia M Prêle
Journal:  Immunol Cell Biol       Date:  2017-03-30       Impact factor: 5.126

Review 6.  Interstital lung disease in ANCA vasculitis.

Authors:  Marco A Alba; Luis Felipe Flores-Suárez; Ashley G Henderson; Hong Xiao; Peiqi Hu; Patrick H Nachman; Ronald J Falk; J Charles Jennette
Journal:  Autoimmun Rev       Date:  2017-05-04       Impact factor: 9.754

7.  Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection.

Authors:  K Kubo; S Yamaguchi; K Fujimoto; M Hanaoka; M Hayasaka; T Honda; T Sodeyama; K Kiyosawa
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

8.  Collagen deposition in a non-fibrotic lung granuloma model after nitric oxide inhibition.

Authors:  C M Hogaboam; C S Gallinat; C Bone-Larson; S W Chensue; N W Lukacs; R M Strieter; S L Kunkel
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

9.  The effect of eosinophils on collagen gel contraction and implications for tissue remodelling.

Authors:  U Zagai; C M Sköld; A Trulson; P Venge; J Lundahl
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

10.  Inhibition of the stem cell factor 248 isoform attenuates the development of pulmonary remodeling disease.

Authors:  Andrew Rasky; David M Habiel; Susan Morris; Matthew Schaller; Bethany B Moore; Sem Phan; Steven L Kunkel; Martin Phillips; Cory Hogaboam; Nicholas W Lukacs
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-20       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.